Letter to the Editor: Bad-risk childhood pleuropulmonary blastoma: Does chemoradiotherapy help?

Pleuropulmonary blastoma is a rare and aggressive primary intrathoracic neoplasm of children. T'he prognosis is extremely poor with frequent metastasis to the brain and bone. A 4-year-old boy successfully treated with multimodal therapy despite unfavorable prognostic factors is presented. The authors support the use of aggressive treatment of pleuropulmonary blastoma with surgery, chemotherapy, and radiotherapy.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Letter to the Editor: Bad-risk childhood pleuropulmonary blastoma: Does chemoradiotherapy help?

Cited by 3 publications

References 7 publications

Pleuropulmonary blastoma

Pleuropulmonary blastoma

Lung tumours in children

Type Ii Pleuropulmonary Blastoma Responsive to Multimodal Therapy

Contact Info

Product

Resources

About